Pulmonary Hypertension News

August 14, 2020August 14, 2020

New 3D Cell Culture Model Allows Study of Arterial Wall Thickening in PAH

A team of researchers have used 3D cell culture technology to develop a model that replicates processes involved in pulmonary arterial hypertension (PAH), allowing them to more carefully analyze the ... Read more

August 12, 2020August 12, 2020

Liquida’s LIQ861 Found to Improve Exercise Capacity, Quality of Life in PAH

Pulmonary Hypertension News

LIQ861, Liquidia Technologies’ proprietary inhaled dry powder formulation of the vasodilator treprostinil, improves exercise capacity and quality of life for people with pulmonary arterial hypertension (PAH), according to data from ... Read more

August 11, 2020August 12, 2020

New Streaming Channel Showcases Rare Disease Films

COVID-19 News, Pulmonary Hypertension News

When the COVID-19 pandemic forced the postponement of a rare disease film festival originally slated for May, its organizers set out to find a new way to bring the films ... Read more

August 10, 2020August 10, 2020

5-year Survival Rate Lower in Congenital Heart Disease Patients With PAH

Pulmonary Hypertension News

The five-year survival rate is markedly reduced among adults with pulmonary arterial hypertension (PAH) due to congenital heart disease (CHD), compared with other types of CHD, real-world data from the ... Read more

August 7, 2020August 7, 2020

Aerovate Raises $72.6M to Develop Potential PAH Inhaled Therapy AV-101

Pulmonary Hypertension News

Aerovate Therapeutics received $72.6 million in Series A funding to advance trials testing AV-101, an experimental inhaled version of imatinib for the treatment of pulmonary arterial hypertension (PAH). AV-101 is an ... Read more

August 3, 2020August 3, 2020

PVR Threshold for Mortality Risk Lower Than Previously Thought

Pulmonary Hypertension News

High pulmonary vascular resistance (PVR) is associated with worse mortality rates among people with pulmonary hypertension (PH), and the bottom threshold for what constitutes “elevated” PVR is lower than previously thought, a ... Read more

July 31, 2020August 3, 2020

Klotho Protein Supplements Improve Pulmonary, Cardiac Function in BPD Rat Model

Pulmonary Hypertension News

Preterm babies with the lung condition bronchopulmonary dysplasia (BPD) — a risk factor for the development of pulmonary hypertension (PH) — have lower levels of the anti-aging-associated protein Klotho, a ... Read more

July 29, 2020July 29, 2020

PAH Caused by Undiagnosed Systemic Sclerosis in Case Study

Pulmonary Hypertension News

A case report found a patient’s pulmonary arterial hypertension (PAH) was caused by an undiagnosed case of the autoimmune disorder systemic sclerosis (SSc), highlighting the need for early and thorough diagnostic ... Read more

July 27, 2020July 28, 2020

Outcomes Better for PAH Patients Treated at Specialty Centers, Study Finds

Pulmonary Hypertension News

People with pulmonary arterial hypertension (PAH) who are treated at specialty care centers have better survival chances and a lower likelihood of hospitalization, a study reports. These findings support referring ... Read more

July 24, 2020July 24, 2020

Patient Advocate in Latin America Wins Team PHenomenal Hope Research Grant

Pulmonary Hypertension News

Paula Menezes has been awarded a $50,000 PHenomenal Impact Fund for Global PH Research grant to identify challenges faced by pulmonary hypertension (PH) patients and caregivers in parts of Latin ... Read more

July 22, 2020July 22, 2020

Opsumit Can Lower Mortality Risk in PAH Patients, Study Contends

Pulmonary Hypertension News

When used alone or in combination with other therapies, Opsumit (macitentan) can lower the mortality risk in patients with pulmonary arterial hypertension (PAH), a study found. The study, “Changes in ... Read more

July 20, 2020July 20, 2020

Specialist Care Needed Throughout High-risk Pregnancies of PAH Patients, Study Says

Pulmonary Hypertension News

Pregnant women with pulmonary arterial hypertension (PAH) should seek specialist care before giving birth and for months afterward, due to the risk of severe maternal complications and high rates of ... Read more

July 17, 2020July 17, 2020

Interleukin-32 Shows Potential as Early Biomarker for PAH in Scleroderma Patients

Pulmonary Hypertension News

A protein called interleukin-32 may serve as a biomarker for pulmonary arterial hypertension (PAH) in scleroderma patients, for whom PAH is a severe complication. The study reporting the findings, “Interleukin-32 in ... Read more

July 15, 2020July 15, 2020

Liquidia to Expand PAH Treatment Efforts With RareGen Acquisition

Pulmonary Hypertension News

Liquidia Technologies, a company developing an inhaled form of treprostinil for pulmonary arterial hypertension (PAH), has established an agreement to acquire the rare disease company and marketer of generic treprostinil injections, ... Read more

July 13, 2020July 13, 2020

Certain US Veterans More Likely to be Inappropriately Prescribed PDE5 Inhibitors

Pulmonary Hypertension News

U.S. veterans with pulmonary hypertension (PH) due to left heart disease and chronic lung disease are more likely to be inappropriately prescribed phosphodiesterase-5 inhibitors (PDE5i) if they have received care ... Read more